CUSIP 640268306COM NEWNKTRQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
172 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bvf Inc/Il | 1.56M | $65.94M | +283.0K | Added |
| 2 | Vanguard Group Inc | 1.03M | $43.43M | +78.4K | Added |
| 3 | Two Seas Capital LP | 745.2K | $31.51M | +745.2K | New |
| 4 | Blackrock, Inc. | 645.6K | $27.30M |
| Added |
| 5 | Armistice Capital, LLC | 596.0K | $25.20M | +328.0K | Added |
| 6 | Morgan Stanley | 566.4K | $23.95M | −362.7K | Reduced |
| 7 | Prosight Management, LP | 554.6K | $23.45M | +554.6K | New |
| 8 | Two Sigma Investments, LP | 473.0K | $20.00M | +38.8K | Added |
| 9 | Invesco Ltd. | 468.2K | $19.79M | +241.3K | Added |
| 10 | Millennium Management LLC | 454.1K | $19.20M | −91.9K | Reduced |
See every fund holding Nektar Therapeutics, with full quarter-over-quarter share changes.
Unlock all holders